¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Super Urinozinc Prostate Form. Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ring-form
    ¹ÝÁöÇü, À±»óü
  • oral
    1. ÀÔ- 2. °æ±¸- 3. ±¸µÎ-, ±¸¼ú- 4. ÀÔ¾È, ±¸°­
  • oral administration
    °æ±¸Åõ¿©
  • oral angle
    ÀÔ²¿¸®
  • oral arch
    ÀÔõÀåȰ, ±¸°³±Ã
  • oral bacteriology
    ±¸°­¼¼±ÕÇÐ
  • oral bacterium
    ÀÔ¼Ó±Õ
  • oral candidiasis
    ÀÔ¾ÈÄ­µð´ÙÁõ, ±¸°­Ä­µð´ÙÁõ
  • oral cavity
    ÀÔ¾È, ±¸°­
  • oral character
    ±¸°­±â¼º°Ý
  • oral cholecystography
    °æ±¸¾µ°³(ÁÖ¸Ó´Ï)Á¶¿µ(¼ú), °æ±¸´ã³¶Á¶¿µ(¼ú)
  • oral contraception
    °æ±¸ÇÇÀÓ(¹ý)
  • oral contraceptive
    °æ±¸ÇÇÀÓÁ¦, ¸Ô´ÂÇÇÀÓÁ¦
  • oral dependence
    ±¸°­ÀÇÁ¸
  • oral eroticism
    ±¸°­±â¼º¿å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oral administration
    °æ±¸Åõ¿©
  • oral angle
    ÀÔ²¿¸®
  • oral arch
    (¢¡palatal arch) ÀÔõÀåȰ
  • oral hypoglycemic agent
    °æ±¸Ç÷´ç°­ÇÏÁ¦
  • oral bacteriology
    ±¸°­¼¼±ÕÇÐ
  • oral bacterium
    ÀÔ¼Ó±Õ
  • oral cavity
    ÀÔ¾È, ±¸°­
  • oral cholecystography
    °æ±¸¾µ°³Á¶¿µ¼ú, °æ±¸´ã³¶Á¶¿µ¼ú
  • oral contraception
    °æ±¸ÇÇÀÓ
  • oral contraceptive
    °æ±¸ÇÇÀÓÁ¦, ¸Ô´ÂÇÇÀÓÁ¦
  • oral dependence
    ±¸°­ÀÇÁ¸
  • oral disease
    ÀÔº´, ±¸°­Áúȯ
  • oral fissure
    ÀÔ¼úÆ´»õ
  • oral floor
    ÀԾȹٴÚ
  • oral flora
    ÀԾȱչ«¸®, ±¸°­±ÕÃÑ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • personality, oral
    ±¸°­¼º ÀΰÝ
  • abscess of prostate
    Àü¸³¼± ³ó¾ç
  • prostate
    Àü¸³»ù, Àü¸³¼±(îñí¡àÍ).
  • prostate
    Àü¸³»ù
  • prostate
    Àü¸³¼±
  • prostate
    Àü¸³¼±(îñí¡àÍ)
  • prostate capsule
    Àü¸³¼±ÇǸ·
  • prostate carcinoma
    Àü¸³¼±¾ÏÁ¾(îñí¡àÍäßðþ)
  • prostate gland
    Àü¸³»ù, Àü¸³¼±(îñí¡àÍ).
  • prostate gland
    Àü¸³¼±
  • prostate specific antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø
  • prostate utricle
    Àü¸³¼±¼Ò½Ç
  • prostate-specific antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø(îñí¡àÍ÷åì¶ù÷ê«)
  • prostate-specipic antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • disseminated part of prostate
    Àü¸³»ùÆÛÁüºÎºÐ
  • fascia of prostate
    Àü¸³»ù±Ù¸·
  • isthmus of prostate
    Àü¸³»ùÀß·è
  • levator muscle of prostate<³ª> musculus l. prostatae
    Àü¸³¼±(îñí¡àÍ)°Å±Ù.
  • ligament of prostate
  • prostate
    Àü¸³»ù, Àü¸³¼±(îñí¡àÍ).
  • prostate
    Àü¸³»ù
  • prostate
    Àü¸³¼±
  • prostate
    Àü¸³¼±(îñí¡àÍ)
  • prostate capsule
    Àü¸³¼±ÇǸ·
  • prostate carcinoma
    Àü¸³¼±¾ÏÁ¾(îñí¡àÍäßðþ)
  • prostate gland
    Àü¸³»ù, Àü¸³¼±(îñí¡àÍ).
  • prostate gland
    Àü¸³¼±
  • prostate specific antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø
  • prostate utricle
    Àü¸³¼±¼Ò½Ç
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Septum of prostate
    Àü¸³»ù»çÀ̸·
    [¿¾ ¿ë¾î] Àü¸³¼±Áß°Ý
  • Isthmus of prostate
    Àü¸³»ùÀß·è
    [¿¾ ¿ë¾î] Àü¸³¼±ÇùºÎ
  • Capsule of prostate
    Àü¸³»ùÇǸ·
    [¿¾ ¿ë¾î] Àü¸³¼±ÇǸ·
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oral mucosa
    ±¸°­Á¡¸·
  • oral surgery
    ±¸°­¿Ü°ú(ÇÐ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OCP octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil...
OET oral endotracheal tube; oral esophageal tube
OHI Occupational Health Institute; operative hypertension indicator; oral hygiene index; Oral Hygiene In...
BPH Benign Prostate(Prostatic) Hypertrophy(Hyperplasia); Àü¸³¼± ºñ´ë(Áõ)
PSA Prostate(Prostatic)-Specific Antigen; Àü¸³¼± ƯÀÌ Ç׿ø
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HGSHS:A Harvard Group Scale of Hypnotic Susceptibility, Form A
MOS SF-36 Medical Outcome Study Short Form 36
PAF Premenstrual Assessment Form
SF36 SHORT FORM 36
SF Short Form
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • box-form
    »óÇü ¿Íµ¿ÀÇ
  • chemical form
    È­ÇÐÀû Çü»ó
  • circumscribed form
    ±¹ÇѼº ÇüÅÂ
  • color form sorting test
    »öä ÇüÅ Ã߸®±â °Ë»ç
  • convenience form
    ÆíÀÇ ÇüÅÂ
    ÃæÀü¿¡ ÇÊ¿¬ÀûÀÎ ±âº»ÀûÀÎ ¿Íµ¿ÀÇ ÇüÅ·μ­ ¿Íµ¿Àº ¾ðÁ¦³ª ¸ðµç ÃæÀü Á¶ÀÛ¿¡ À־ ±× Á¶ÀÛÀ» ÆíÇÏ°Ô ÇÒ ¼ö ÀÖ´Â ÀûÀýÇÑ ÇüÅ·Π¿Íµ¿À» Çü¼ºÇÏ´Â °Í.
  • crescent form
    ¹Ý´ÞÇü, ¹Ý¿ùü, ¹Ý¿ùÇü
  • facial form
    ¾È¸ð
  • form-other
    Çü½Ä»óÀÇ ¸ñ
  • initial form
    Ãʱâ ÇüÅÂ
  • L-form
    L-Çü
  • large surface form
    ³ÐÀº ¸éÀÇ ÇüÅÂ
  • lethal form
    Ä¡»çÀûÀÎ ÇüÅÂ
  • liquid form
    ¾×ü »óÅÂ
    ¹°À̳ª ±â¸§°ú °°ÀÌ ÀÚÀ¯·ÎÀÌ À¯µ¿ÇÏ¿© ¿ë±âÀÇ ¸ð¾ç¿¡ µû¶ó ±× ¸ð¾çÀÌ º¯Çϸç ÀÏÁ¤ÇÑ ÇüŸ¦ °¡ÁöÁö ¾Ê°í ¾ÐÃàÇØµµ °ÅÀÇ ºÎÇǰ¡ º¯ÇÏÁö ¾Ê´Â ¹°Áú. Á¤È®È÷´Â ¾×ü »óŶó°í ÇÑ´Ù. ¼ö¸¹Àº ¹°Áú °¡¿îµ¥ »ó¿Â, »ó¾Ð¿¡¼­ ÀÌ¿Í °°Àº »óŸ¦ °¡Áö´Â °ÍÀº ºñ±³Àû ÀûÀ¸³ª, Àû´çÇÑ ¿Âµµ¿Í ¾Ð·ÂÀÇ Á¶°ÇÀÌ °®Ãß¾îÁö¸é °ÅÀÇ ¸ðµç ¹°ÁúÀÌ ¾×ü·Î º¯ÇÒ ¼ö ÀÖÀ¸¸ç, ¹Ý´ë·Î ¾×üµµ ´Ù½Ã ±âü³ª °íü·Î º¯ÇÒ ¼ö ÀÖ´Ù. Áï, ¾×ü¶ó´Â °ÍÀº ¹°Áú¿¡ °íÀ¯ÇÑ ¼ºÁúÀÌ ¾Æ´Ï¶ó Á¶°Ç¿¡ µû¶ó¼­ ±âü·Îµµ °íü·Îµµ º¯ÇÒ ¼ö ÀÖ´Â ¹°ÁúÀÇ Á¸Àç »óÅÂÀÇ Çϳª¿¡ ºÒ°úÇÏ´Ù. ÀÌ·± ¶æ¿¡¼­ °íü»ó, ±âü»ó¿¡ ´ëÇØ¼­ ¾×ü»óÀ̶ó°í ÇÏ´Â °æ¿ìµµ ÀÖ´Ù. ¶ÇÇÑ ÇϳªÀÇ ¹°ÁúÀÌ °íü¿¡¼­ ¾×ü·Î º¯È­ÇÏ´Â Çö»óÀ» À¶ÇØ, ¾×ü¸é¿¡¼­ ±âÈ­ÇÏ´Â °ÍÀ» Áõ¹ßÀ̶ó°í Çϳª, ±âÈ­´Â ¾×ü ³»ºÎ¿¡¼­µµ ÀϾ¸ç, ¾×ü°¡ Àü¸éÀûÀ¸·Î ±âü·Î º¯ÇÏ´Â Çö»óÀ» ºñµîÀ̶ó°í ÇÑ´Ù. ÀÏÁ¤ÇÑ ¾Ð·ÂÇÏ¿¡¼­ÀÇ
  • localized form
    ±¹¼Ò Çü
  • marginal form
    ¿Ü¿¬ ÇüÅÂ, º¯¿¬ ÇüÅÂ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
prostate gland A gland in the male that surrounds the neck of the bladder and urethra. The prostate contributes to the seminal fluid.
(16 Dec 1997)
prostate-specific antigen <tumour marker> A simple blood test used to detect prostate cancer in men. The test measures a specific antigen normally secreted by the prostate. If cancer is developing, the prostate secretes greater amounts of prostate-specific antigen. This test is recommended for men with an enlarged prostate and an increased risk of prostate cancer.
It is an enzyme that is produced by epithelial cells of both benign and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
It is a single chain 31 kilodalton glycoprotein with 240 amino acid residues and 4 carbohydrate side chains that is a kallikrein protease.
It is found in normal seminal fluid and produced by the prostatic epithelial cells.
Elevated levels in blood serum are associated with prostatic enlargement and prostatic adenocarcinoma, and this allows early detection of cancer in many cases. In about 70% of cases, the rise is due to a cancerous condition.
No large scale clinical studies have been completed to assess the impact of testing on survival from prostate cancer, and the medical and economic value of testing remain uncertain.
Acronym: PSA
Registry number: EC 3.4.21.77
(22 Sep 2002)
nodular hyperplasia of prostate Glandular and stromal hyperplasia occurring very commonly in the middle and lateral lobes of older men, forming nodules that may increasingly obstruct the urethra.
Synonym: benign prostatic hypertrophy.
(05 Mar 2000)
inferolateral surface of prostate The surface of the prostate facing the body of the pubis and the pelvic diaphragm.
Synonym: facies inferolateralis prostatae.
(05 Mar 2000)
isthmus of prostate The narrow middle part of the prostate anterior to the urethra.
Synonym: isthmus prostatae.
(05 Mar 2000)
elevator muscle of prostate <anatomy> In the male, the most medial fibres of the levator ani (pubococcygeus) muscle that extend from the pubis into the fascia of the prostate.
Synonym: musculus levator prostatae, elevator muscle of prostate.
(05 Mar 2000)
fascia of prostate The condensation of pelvic visceral fascia that encloses the prostate gland.
Synonym: fascia prostatae.
(05 Mar 2000)
female prostate Term sometimes applied to the periurethral glands in the upper part of the urethra in the female.
(05 Mar 2000)
lobe of prostate One of the lateral lobes (right or left) or the middle lobe or isthmus of the prostate; in the adult the lobes are ill-defined.
Synonym: lobus prostatae.
(05 Mar 2000)
a-form DNA <molecular biology> One of several forms that can be assumed by a double helix. A-DNA is stable in dehydrated conditions.
This form is less common than the dominant form found under physiological conditions -- beta-DNA. This form is also assumed by DNA-RNA hybrid helices and by regions of double-stranded RNA. It is a right-handed helix and is a more compact form than beta-DNA.
(09 Oct 1997)
boat form The less stable of two conformations assumed by 6-membered cyclic sugars (pyranoses) or cyclohexane derivatives, as opposed to chair form.
See: Haworth conformational formulas of cyclic sugars.
(05 Mar 2000)
cavity preparation form The configuration or shape of a cavity preparation.
(05 Mar 2000)
replicative form An intermediate stage in the replication of either DNA or RNA viral genomes that is usually double stranded, the altered, double-stranded form to which single-stranded coliphage DNA is converted after infection of a susceptible bacterium, formation of the complementary ("minus") strand being mediated by enzymes that were present in the bacterium before entrance of the viral ("plus") strand.
(05 Mar 2000)
resistance form The shape given to a cavity preparation that enables the dental restoration to withstand masticatory forces.
(05 Mar 2000)
retention form The shape of a cavity preparation that prevents displacement of the dental restoration by lateral or tipping forces as well as masticatory forces.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • form criticism
    ¾ç½Ä ºñÆòÇÐ
  • form frag
    (À¯Ã¼ ¼ÓÀ» ¿îµ¿ÇÏ´Â ¹°Ã¼ÀÇ) Çü»ó Ç×·Â
  • form genus
    ÇüżÓ
  • form letter
    °°Àº ±ÛÀÇ ÆíÁö(Àμâ,º¹»çµÈ)
  • form master
    ÇÐ±Þ ´ãÀÓ ±³»ç
  • form sheet
    (°æ¸¶ÀÇ) ¿¹»óÁö;(Èĺ¸ÀÚ,°æ±âÀÚ¿¡ °üÇÑ) »ó¼¼ÇÑ ±â·Ï
  • form word
    =FUNCTON WORD
  • free form
    ÀÚÀ¯Çü½Ä
  • inner speech form
    ³»ºÎ ¾ð¾î Çü½Ä
  • progressive form
    ÁøÇàÇü
  • racing form
    °æ¸¶ ½Å¹®
  • re-form
    ´Ù½Ã(°íÃÄ)¸¸µé´Ù;ÀçÆí¼º(°³Æí)ÇÏ´Ù;´Ù½Ã ÇüÅ·ΠÀÌ·ç´Ù
  • sonata form
    ¼Ò³ªÅ¸ Çü½Ä
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á